According to Tonghe Pharmaceutical's announcement, Pang Zhengwei, the controlling shareholder and one of the actual controllers of the company, has pledged 8.3 million shares, accounting for 13.38% of his shares and 1.98% of the company's total share capital. The starting date of the pledge is September 4, 2026, and the expiration date is September 1, 2029. The pledger is Guojin Securities Co., Ltd., and the purpose of the pledge is personal capital requirements. After this pledge, Pang Zhengwei and his co-actors pledged a total of 12.41 million shares, accounting for 10.22% of the total shareholding ratio and 2.96% of the company's total share capital. There is no risk of liquidation or compulsory transfer of the current pledge, and does not affect the company's production, operation and governance.

According to Tonghe Pharmaceutical's announcement, Pang Zhengwei, the controlling shareholder and one of the actual controllers of the company, has pledged 8.3 million shares, accounting for 13.38% of his shares and 1.98% of the company's total share capital. The starting date of the pledge is September 4, 2026, and the expiration date is September 1, 2029. The pledger is Guojin Securities Co., Ltd., and the purpose of the pledge is personal capital requirements. After this pledge, Pang Zhengwei and his co-actors pledged a total of 12.41 million shares, accounting for 10.22% of the total shareholding ratio and 2.96% of the company's total share capital. There is no risk of liquidation or compulsory transfer of the current pledge, and does not affect the company's production, operation and governance.